+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Respiratory Diagnostics Market by Diagnostic Tests (Blood Tests, Imaging Tests, Lung Function Tests), Patient Demographics (Adult, Geriatric, Pediatric), Offerings, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5914461
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The respiratory diagnostics market is evolving rapidly as healthcare providers seek solutions that deliver greater efficiency and enable data-driven clinical decisions. Senior executives require actionable intelligence to navigate technological advances, shifting regulations, and evolving patient care strategies within this dynamic sector.

Respiratory Diagnostics Market Snapshot

The Respiratory Diagnostics Market grew from USD 6.66 billion in 2024 to USD 7.26 billion in 2025. It is expected to continue growing at a CAGR of 8.66%, reaching USD 10.97 billion by 2030. This expansion highlights a robust demand for accurate, rapid, and integrated testing solutions as providers respond to both increasing chronic disease prevalence and the demand for enhanced patient monitoring. The sector encompasses a range of innovative modalities, spanning from traditional imaging to advanced molecular testing.

Scope & Segmentation

  • Diagnostic Test Types: Blood tests, imaging tests, lung function assessments, molecular assays, pulse oximetry, and sputum analysis are key components shaping clinical pathways and technology planning.
  • Patient Demographics: Solutions are developed for adult, geriatric, and pediatric patient segments, each with unique clinical requirements and workflow preferences.
  • Offerings: The market covers equipment such as body plethysmographs, imaging systems, gas analyzers, and spirometry devices, in addition to a spectrum of services and advanced diagnostic software.
  • End Users: Core buyers and influencers comprise academic institutions, diagnostic labs, hospitals and clinics, and research institutes, each driving demand through specific use cases and procurement strategies.
  • Geographies: Americas, Europe, Middle East & Africa, and Asia-Pacific, with country-level insights for regions including the United States, Canada, Brazil, Germany, China, India, and Japan.
  • Technologies: Integration of molecular diagnostics, AI-powered analytics, wearable devices, portable hardware, and digital health platforms is redefining testing standards and interoperability needs.
  • Key Companies: Vendors analyzed span Becton, Dickinson and Company, Abbott Laboratories, GE HealthCare Technologies, Siemens Healthineers AG, Medtronic PLC, Thermo Fisher Scientific Inc., and additional relevant players.

Key Takeaways for Senior Decision-Makers

  • Emerging molecular testing tools and high-throughput assays are central to improving early detection and supporting tailored treatment regimens for respiratory conditions.
  • The sector is witnessing adoption of digital diagnostic platforms that streamline data integration from devices, electronic health records, and remote monitoring sources.
  • Collaboration between technology vendors, research institutions, and healthcare providers is accelerating the validation and deployment of novel testing solutions.
  • Demographic shifts, particularly in aging and pediatric populations, require the adaptation of minimally invasive and patient-centered testing protocols.
  • Regulatory adaptation and reimbursement policy evolution remain critical in enabling market access for advanced diagnostic technologies, driving provider investments and influencing procurement frameworks.
  • Competitive advantage is shaped by product portfolio depth, the ability to offer integrated software-hardware ecosystems, and responsiveness to regional healthcare infrastructure differences.

Tariff Impact on Respiratory Diagnostics

Recent United States tariffs on diagnostic components have increased operational costs and driven a need for adaptive procurement strategies. Organizations are mitigating risks by diversifying suppliers, renegotiating contracts, and considering domestic as well as allied regional manufacturing. Proactive risk management through these measures supports supply chain continuity and ensures uninterrupted access to critical testing platforms and consumables.

Methodology & Data Sources

The report utilizes a mixed-methods approach, combining interviews with industry experts—laboratory leaders, clinical specialists, and executives—with secondary research from peer-reviewed sources, regulatory filings, and proprietary databases. Analytical models, including SWOT and Porter’s Five Forces, supplement expert perspectives, while rigorous validation protocols assure reliability and contextual relevance.

Why This Report Matters

  • Delivers strategic guidance for prioritizing R&D, technology adoption, and procurement initiatives in an evolving diagnostic landscape.
  • Enables benchmarking across global regions, helping leaders align investments with local market dynamics and regulatory realities.
  • Supports informed decision-making by highlighting actionable trends, risk factors, and best practices relevant to respiratory diagnostics market leadership.

Conclusion

Senior stakeholders in respiratory diagnostics are challenged to adapt rapidly to technological, regulatory, and clinical changes. This report provides essential insights for navigating evolving market demands and advancing patient-centered care strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of point-of-care molecular testing for rapid identification of respiratory pathogens
5.2. Integration of AI-driven algorithms in pulmonary function testing for early disease detection
5.3. Surge in utilization of home-based spirometry devices with smartphone connectivity for chronic obstructive pulmonary disease monitoring
5.4. Rising investments in portable aerosol analysis platforms for real-time monitoring of airborne pathogens
5.5. Emergence of multiplex real-time PCR panels enabling simultaneous detection of multiple respiratory viruses
5.6. Expansion of CRISPR-based assays for highly sensitive detection of emerging respiratory pathogens in clinical settings
5.7. Development of breathomics technology for non-invasive biomarker profiling in respiratory disease diagnosis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Diagnostics Market, by Diagnostic Tests
8.1. Introduction
8.2. Blood Tests
8.2.1. Arterial Blood Gases
8.2.2. Complete Blood Count
8.3. Imaging Tests
8.3.1. Chest X-Rays
8.3.2. CT Scans
8.3.3. MRI Scans
8.4. Lung Function Tests
8.4.1. Diffusion Capacity Tests
8.4.2. Lung Volume Tests
8.4.3. Spirometry
8.5. Molecular Tests
8.5.1. Antigen Tests
8.5.2. Biomarker Tests
8.5.3. PCR Tests
8.6. Pulse Oximetry
8.7. Sputum Tests
9. Respiratory Diagnostics Market, by Patient Demographics
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Respiratory Diagnostics Market, by Offerings
10.1. Introduction
10.2. Equipment
10.2.1. Body Plethysmographs
10.2.2. Diagnostic Imaging Systems
10.2.3. Gas Analysis Devices
10.2.4. Spirometry Systems
10.3. Services
10.4. Software
10.4.1. Data Analytics Software
10.4.2. Imaging Analysis Software
10.4.3. Pulmonary Function Testing (PFT) Software
11. Respiratory Diagnostics Market, by End Users
11.1. Introduction
11.2. Academic Institutions
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Research Institutes
12. Americas Respiratory Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Respiratory Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Respiratory Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton, Dickinson, and Company
15.3.2. Abbott Laboratories
15.3.3. Adaltis S.r.l.
15.3.4. Altona Diagnostics GmbH
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. bioMérieux S.A.
15.3.7. Bioneer Corporation
15.3.8. CerTest Biotec S.L.
15.3.9. Daan Gene Co., Ltd.
15.3.10. Diatech Pharmacogenetics srl
15.3.11. Drägerwerk AG & Co. KGaA
15.3.12. F. Hoffmann-La Roche Ltd.
15.3.13. GE HealthCare Technologies, Inc.
15.3.14. Hologic, Inc.
15.3.15. Johnson & Johnson Services, Inc.
15.3.16. Koninklijke Philips N.V.
15.3.17. Masimo Corporation
15.3.18. Medtronic PLC
15.3.19. Merck KGaA
15.3.20. ProAxsis by NetScientific PLC
15.3.21. Quest Diagnostics Incorporated
15.3.22. Quidel Corporation
15.3.23. Sansure Biotech Inc.
15.3.24. SDI Diagnostics, Inc.
15.3.25. Seegene Inc.
15.3.26. Siemens Healthineers AG
15.3.27. ResMed Corp.
15.3.28. Thermo Fisher Scientific Inc.
15.3.29. Vitalograph Ltd.
15.3.30. ZeptoMetrix LLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 142. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 143. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 144. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 145. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 146. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 147. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 148. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 149. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 150. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 151. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 152. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 153. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 154. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 155. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 156. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 157. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 158. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 159. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 160. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 176. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 177. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 278. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 279. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 280. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 285. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 298. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 299. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 302. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Respiratory Diagnostics market report include:
  • Becton, Dickinson, and Company
  • Abbott Laboratories
  • Adaltis S.r.l.
  • Altona Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Bioneer Corporation
  • CerTest Biotec S.L.
  • Daan Gene Co., Ltd.
  • Diatech Pharmacogenetics srl
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic PLC
  • Merck KGaA
  • ProAxsis by NetScientific PLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Sansure Biotech Inc.
  • SDI Diagnostics, Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • ResMed Corp.
  • Thermo Fisher Scientific Inc.
  • Vitalograph Ltd.
  • ZeptoMetrix LLC

Table Information